Artículos publicados

Artículos publicados Encontrados 1 registros  La búsqueda tardó 0.02 segundos. 
1.
11 p, 1.2 MB A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients / Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ; Bermúdez, Arancha (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Logan, Aaron C. (Division of Hematology and Blood and Marrow Transplantation. Department of Medicine. University of California) ; Kharfan-Dabaja, Mohamed A. (Department of Blood and Marrow Transplantation. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida) ; Chevallier, Patrice (Service d'Hématologie Clinique. CHU de Nantes. 44093. Nantes. France and CRCINA / INSERM UMR1232 / CNRS ERL6001 IRS UN - 8) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Wulf, Gerald (Department of Hematology and Medical Oncology. University Medical Center Göttingen) ; Selleslag, Dominik (Department of Hematology. AZ Sint-Jan Brugge-Oostende) ; Kakihana, Kazuhiko (Hematology Division. Tokyo Metropolitan Komagome Hospital) ; Langston, Amelia (Winship Cancer Institute. Emory University) ; Lee, Dong-Gun. (Catholic University of Korea) ; Solano, Carlos (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ; Okamoto, Shinichiro (Division of Hematology. Department of Medicine. Kelo University School of Medicine) ; Smith, Larry R. (Vical) ; Boeckh, Michael (Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center and University of Washington) ; Wingard, John Reid (Division of Hematology & Oncology. Department of Medicine. University of Florida) ; Cywin, Beth (Astellas Pharma Global Development) ; Fredericks, Christine (Astellas Pharma Global Development) ; Lademacher, Christopher (Astellas Pharma Global Development) ; Wang, Xuegong (Astellas Pharma Global Development) ; Young, James (Astellas Pharma Global Development) ; Maertens, Johan (K.U. Leuven and Department of Hematology)
Background: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). [...]
2021 - 10.1016/j.eclinm.2021.100787
EClinicalMedicine, Vol. 33 (march 2021) , p. 100787  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.